Literature DB >> 17638431

Occult placenta accreta: the missing link in the diagnosis of abnormal placentation.

Jerzy Stanek1, Zarius Drummond.   

Abstract

Placenta creta (accreta, increta, or percreta) is a clinically symptomatic condition, usually diagnosed histologically on hysterectomy specimens. At a minimum, focal absence of decidua is the histological finding for this condition; however, excessive amounts of extravillous trophoblasts were recently documented on hysterectomy specimens. The histological finding of basal plate myometrial fibers (BPMF) without intervening decidua in spontaneously delivered placentas, which we term occult placenta accreta (OPA), is not infrequent, even in clinically asymptomatic cases. To prove that OPA is a missing link between normal placental implantation and clinical placenta accreta, CD146 immunohistochemical stains were performed on 25 sections of OPA (study group) and 25 placental sections without BPMF (control group). Implantation-site intermediate trophoblast (ISIT) cell number, thickness, and density were compared between the study and control groups. The ISIT micrometry thickness and cell number at BPMF sites were statistically significantly higher in OPA than in control group and same OPA placentas away from BPMF. There were no statistically significant differences in ISIT density. Therefore, although asymptomatic, OPA features the same histopathology as clinical placenta accreta and may share same pathogenesis, which may include decidual deficiency, abnormal trophoblast/decidua interaction, and/or hypoxia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638431     DOI: 10.2350/06-10-0174.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  10 in total

1.  Ki-67 proliferation index in patients with placenta previa percreta in the third trimester.

Authors:  Nese Hilali; Sezen Kocarslan; Mehmet Vural; Adnan Incebiyik; Aysun Camuzcuoglu; Hakan Camuzcuoglu
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

2.  Temporal heterogeneity of placental segmental fetal vascular malperfusion: timing but not etiopathogenesis.

Authors:  Jerzy Stanek
Journal:  Virchows Arch       Date:  2020-09-12       Impact factor: 4.064

3.  Maternal serum markers, characteristics and morbidly adherent placenta in women with previa.

Authors:  D J Lyell; A M Faucett; R J Baer; Y J Blumenfeld; M L Druzin; Y Y El-Sayed; G M Shaw; R J Currier; L L Jelliffe-Pawlowski
Journal:  J Perinatol       Date:  2015-04-30       Impact factor: 2.521

4.  Placenta Creta: A Spectrum of Lesions Associated with Shallow Placental Implantation.

Authors:  Jerzy Stanek
Journal:  Obstet Gynecol Int       Date:  2020-11-24

5.  Changes in the enhancer landscape during early placental development uncover a trophoblast invasion gene-enhancer network.

Authors:  Geetu Tuteja; Tisha Chung; Gill Bejerano
Journal:  Placenta       Date:  2015-11-06       Impact factor: 3.481

6.  Placental pathology varies in hypertensive conditions of pregnancy.

Authors:  Jerzy Stanek
Journal:  Virchows Arch       Date:  2017-10-02       Impact factor: 4.064

7.  Relaxin, its receptor (RXFP1), and insulin-like peptide 4 expression through gestation and in placenta accreta.

Authors:  William Goh; Sandra Y Yamamoto; Karen S Thompson; Gillian D Bryant-Greenwood
Journal:  Reprod Sci       Date:  2013-01-09       Impact factor: 3.060

Review 8.  Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel.

Authors:  Jonathan L Hecht; Rebecca Baergen; Linda M Ernst; Philip J Katzman; Suzanne M Jacques; Eric Jauniaux; T Yee Khong; Leon A Metlay; Liina Poder; Faisal Qureshi; Joseph T Rabban; Drucilla J Roberts; Scott Shainker; Debra S Heller
Journal:  Mod Pathol       Date:  2020-05-15       Impact factor: 7.842

9.  PRG2 and AQPEP are misexpressed in fetal membranes in placenta previa and percreta†.

Authors:  Elisa T Zhang; Roberta L Hannibal; Keyla M Badillo Rivera; Janet H T Song; Kelly McGowan; Xiaowei Zhu; Gudrun Meinhardt; Martin Knöfler; Jürgen Pollheimer; Alexander E Urban; Ann K Folkins; Deirdre J Lyell; Julie C Baker
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

Review 10.  Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers.

Authors:  Helena C Bartels; James D Postle; Paul Downey; Donal J Brennan
Journal:  Dis Markers       Date:  2018-07-03       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.